CXCR2 and neoplasm: Their trafficking and infiltration into solid tumors is frequently suboptimal, although this can be improved by engineering expression of chemokine receptors such as CXCR4, CXCR1, or CXCR2 to match tumor-secreted ligands [79,80,81,153,154].